I
Invivyd Inc. (IVVD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$0.54
-0.04 (-7.63%)
Market Cap: $171.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
Invivyd Inc. (IVVD) Valuation Multiples
Invivyd (IVVD) trades at 2.9x sales and 1.2x book value. Its P/B of 1.2x is in line with its 5-year median. Its forward P/E is 7.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 7.0x |
| Price to sales | 2.9x |
| Price to book | 1.2x |
| PEG | N/A |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 1.2x | 1.2x | N/A |
Valuation History
Over the 3 of the 5 year ends shown that have a P/S, its P/S ranged from 2.1x in 2024 to 143.1x in 2023.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $2.47 | 6.7x | 1.8x |
| 2024 | $0.44 | 2.1x | 0.8x |
| 2023 | $3.94 | 143.1x | 2.4x |
| 2022 | $1.50 | N/A | 0.5x |
| 2021 | $7.26 | N/A | 0.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IVVD
What is IVVD's forward P/E ratio?
Invivyd has a forward P/E ratio of 7.0x.
Is IVVD stock overvalued?
GNG's valuation label for IVVD is Undervalued.
What is IVVD's price to sales ratio?
Invivyd has a price to sales ratio of 2.9x.
IVVD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors